A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

NCT07723963 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Myoclonic Epilepsy

Interventions

DRUG: JZP926 capsule
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals